| |
|
|
|
VistaGen Therapeutics Inc.  
|
|
1.39 0.21 (0.18%) |
10-18 15:59 |
|
Open: |
1.2 |
Pre close: |
1.18 |
Target:
|
1.62 
|
|
High: |
1.39 |
Low: |
1.2 |
Resistance:
|
1.39
1.62
|
|
Volume: |
798,412 |
Market Cap: |
59M |
Support:
|
1.12
0.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.21
|
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
1.13 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
0.80 |
Stochastic Oscillator |
%K(14,3):
|
85.56 |
|
MA(250): |
1.17  |
%D(3): |
77.97 |
|
Average Volume(K) |
3-Month: |
34218
|
52-Week |
High:
|
2.29 |
|
10-Days: |
29948 |
Low: |
0.38 |
|
RSI |
RSI(14):
|
69.93 |
Change(%): |
-36.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.829 |
Return on Equity (ttm) |
-451.4 |
Shares Out. (M) |
42.62 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-156.6 |
Shares Float (M) |
37.52 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.75 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.61 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1470 |
|
Book Value (p.s.) |
0.040 |
EBITDA (p.s.) |
-0.621 |
P/E |
-1.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
34.75 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.15 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.08 |
P/CF |
-3.67 |
|
|
|
|
|
|
